Post Tagged with: "NASDAQ:LGND"

Biotech Insider Buying: Synageva BioPharma Corp. (NASDAQ:GEVA), VIVUS Inc. (NASDAQ:VVUS), TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)

January 13, 2015 at 2:44 pm 0 comments

Synageva BioPharma Corp. (NASDAQ:GEVA), Director Julian Baker acquired 1,000,000 shares of Synageva BioPharma Corp. (NASDAQ:GEVA) stock in a transaction that occurred on Wednesday, January 7th. The shares were purchased at an average cost of $94.19 per share, for a totalRead More

Investors Are Eying: SCYNEXIS (NASDAQ:SCYX), Itau Unibanco Holding SA (NYSE:ITUB), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Enphase Energy (NASDAQ:ENPH), CommunityOne Bancorp (NASDAQ:COB)

January 10, 2015 at 1:45 pm 0 comments

Drug discovery and development company SCYNEXIS, Inc. (NASDAQ:SCYX) announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track designation for the oral formulation of SCY-078, the Company’s novel antifungal product in development for the treatment of invasiveRead More

Traders Should Watch: QUALCOMM (NASDAQ:QCOM), Wal-Mart Stores Inc. (NYSE:WMT), Qunar Cayman Islands Limited (NASDAQ:QUNR), ON Semiconductor Corp. (NASDAQ:ONNN), Ligand Pharmaceuticals (NASDAQ:LGND)

Traders Should Watch: QUALCOMM (NASDAQ:QCOM), Wal-Mart Stores Inc. (NYSE:WMT), Qunar Cayman Islands Limited (NASDAQ:QUNR), ON Semiconductor Corp. (NASDAQ:ONNN), Ligand Pharmaceuticals (NASDAQ:LGND)

January 6, 2015 at 3:40 pm 0 comments

Qualcomm Incorporated (NASDAQ: QCOM) nnounced that its subsidiaries, Qualcomm Technologies, Inc. (QTI) and Qualcomm Atheros, Inc. (QCA), will showcase a range of new connected mobile computing experiences at CES that will highlight a new level of connectivity and immersive userRead More

Investor’s Choice: Alibaba (NYSE:BABA), Host Hotels & Resorts (NYSE:HST), Stewart Information Services (NYSE:STC), Ever-Glory International Group (NYSEMKT:EVK), Ligand Pharmaceuticals (NASDAQ:LGND)

January 2, 2015 at 11:56 am 0 comments

Alibaba Group Holding Ltd. (NYSE:BABA), which faced scrutiny for selling counterfeit goods on its websites, on 23 December said it removed 90 million listings that may have breached intellectual-property rights. Alibaba Group Holding Ltd (NYSE:BABA) in last trading activity movedRead More

Stocks News Alert: Denbury Resources Inc. (NYSE:DNR), McDermott International Inc. (NYSE:MDR), Tidewater Inc. (NYSE:TDW), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Crocs (NASDAQ:CROX)

January 2, 2015 at 7:09 am 0 comments

Shares of Denbury Resources (NYSE:DNR) have been given an average recommendation of “Hold” by the seventeen analysts that are covering the company, Denbury Resources Inc. (NYSE:DNR) in last trading activity moved down -0.37% to close at $8.13. Company weekly performanceRead More

Watch 5 Stocks: CBS Corporation (NYSE:CBS), Avon Products (NYSE:AVP), Stanley Black & Decker (NYSE:SWK), Ligand Pharmaceuticals (NASDAQ:LGND), Permian Basin Royalty Trust (NYSE:PBT)

December 30, 2014 at 11:32 am 0 comments

On 11 December CBS Corporation (NYSE:CBS) garnered 16 Golden Globe Award nominations across five divisions – SHOWTIME, CBS Television Studios, CBS Television Network, The CW and CBS Films – including triple crown recognition for the third year in a rowRead More

Mix Sector Stocks: Rexahn Pharmaceuticals (NYSEMKT:RNN), Freeport-McMoRan Inc. (NYSE:FCX), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Lantronix (NASDAQ:LTRX), ESCO Technologies Inc. (NYSE:ESE)

December 29, 2014 at 3:23 pm 0 comments

Zacks upgraded shares of Rexahn Pharmaceuticals (NYSE:RNN) from a neutral rating to an outperform rating in a report issued on Tuesday. They currently have $0.80 target price on the stock. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) in last trading activity moved downRead More

Market Alert: CTI BioPharma Corp. (NASDAQ:CTIC), Magnum Hunter Resources Corp. (NYSE:MHR), Cogent Communications Holdings (NASDAQ:CCOI), JDS Uniphase (NASDAQ:JDSU), Ligand Pharmaceuticals (NASDAQ:LGND)

December 29, 2014 at 3:06 pm 0 comments

CTI BioPharma Corp (NASDAQ:CTIC) CEO James A. Bianco sold 40,000 shares of the stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $2.44, for a total value of $97,600.00. FollowingRead More

Traders Are Gambling on: Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Bank of America (NYSE:BAC), Ampio Pharmaceuticals (NYSEMKT: AMPE), Koss Corporation (NASDAQ:KOSS), Nuance Communications (NASDAQ:NUAN)

December 29, 2014 at 7:24 am 0 comments

On 22 December Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced that its partner GlaxoSmithKline (GSK) plc reported the submission of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration for eltrombopag (Promacta), seeking an additional indication in pediatricRead More

Investor’s pick: National Bank of Greece (ADR) (NYSE:NBG), The Coca-Cola Company (NYSE:KO), Hydrogenics Corporation (NASDAQ:HYGS), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Merck (NYSE:MRK)

December 18, 2014 at 2:36 pm 0 comments

National Bank of Greece (ADR) (NYSE:NBG) has a short ratio of 15.7 , which means that the counter should take 15.7 days to cover the total short interest. A high short ratio indicates a high build-up of short positions inRead More